menu search

CNSP / CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, will participate in the Virtual Investor 2022 Top Picks Conference on Wednesday, January 26, 2022 at 11:00 AM ET. As part of the virtual event, the Company will provide a corporate presentation, followed by a moderated interactive Q&A session. Read More
Posted: Jan 20 2022, 08:45
Author Name: PRNewsWire
Views: 110655

CNSP News  

CNS Pharmaceuticals (NASDAQ: CNSP) to Present at the H.C. Wainwright 25th Annual Global Investment Conference

By Accesswire
September 5, 2023

CNS Pharmaceuticals (NASDAQ: CNSP) to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Live webcast presentation on Wednesday, September 13th at 10:30 AM ET HOUSTON, TX / ACCESSWIRE / September 5, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ more_horizontal

CNS Pharmaceuticals to Present at the Virtual Investor GBM Spotlight Event

By PRNewsWire
March 29, 2023

CNS Pharmaceuticals to Present at the Virtual Investor GBM Spotlight Event

Live moderated video webcast with members of CNS Pharmacetucals management and Key Opinion Leader, Professor Michael Weller, MD, on Tuesday, April 4 t more_horizontal

Is CNS Pharmaceuticals, Inc. (CNSP) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
January 20, 2022

Is CNS Pharmaceuticals, Inc. (CNSP) Outperforming Other Medical Stocks This Year?

Here is how CNS Pharmaceuticals, Inc. (CNSP) and Celyad SA (CYAD) have performed compared to their sector so far this year. more_horizontal

Is CNS Pharmaceuticals, Inc. (CNSP) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
January 20, 2022

Is CNS Pharmaceuticals, Inc. (CNSP) Outperforming Other Medical Stocks This Year?

Here is how CNS Pharmaceuticals, Inc. (CNSP) and Celyad SA (CYAD) have performed compared to their sector so far this year. more_horizontal

Is CNS Pharmaceuticals, Inc. (CNSP) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
January 20, 2022

Is CNS Pharmaceuticals, Inc. (CNSP) Outperforming Other Medical Stocks This Year?

Here is how CNS Pharmaceuticals, Inc. (CNSP) and Celyad SA (CYAD) have performed compared to their sector so far this year. more_horizontal

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

By PRNewsWire
January 20, 2022

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in more_horizontal

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

By PRNewsWire
January 20, 2022

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in more_horizontal

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

By PRNewsWire
January 20, 2022

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in more_horizontal


Search within

Pages Search Results: